<DOC>
	<DOCNO>NCT00209430</DOCNO>
	<brief_summary>The main purpose study evaluate compare effect kidney function two contrast medium , iso-osmolar iodixanol low-osmolar iopamidol patient risk kidney damage associate injection contrast medium . A standard hydration procedure , base available guideline give patient prevent negative effect kidney . Serum creatinine ( SCr ) concentration measure 7 day contrast medium administration evaluate effect renal function .</brief_summary>
	<brief_title>Renal Effects Two Iodinated Contrast Media Patients Risk Undergoing Coronary Angiography</brief_title>
	<detailed_description>GEHC decide provide detail</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Subjects combination diabetes mellitus ( type I II ) renal impairment , define serum creatinine ( SCr ) ≥150 µmol/L ( 1.7 mg/dL ) men ≥133 µmol/L ( 1.5 mg/dL ) woman creatinine clearance ( CrCl ) ≤ 50 mL/min calculate accord CockroftGault formula , refer coronary angiography without PCI . Concurrent administration potentially nephroprotective nephrotoxic drug allow . Subjects undergoing dialysis kidney transplant include .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Iodixanol</keyword>
	<keyword>Iopamidol</keyword>
	<keyword>coronary angiography</keyword>
	<keyword>Contrast media-induced nephropathy</keyword>
</DOC>